Research
Imfinzi & Imjudo Immunotherapy Drug Combinations Approved in the EU for the Treatment of Advanced Liver Cancer
The combination of durvalumab (Imfinzi) and tremelimumab (Imjudo) immunotherapies has been approved by the European Commission (EC) for the first-l...
Zolbetuximab Plus Chemotherapy Extends Overall Survival for Patients with Advanced or Metastatic Gastric & Gastro-oesophageal Junction Adenocarcinoma
The Annual American Society of Clinical Oncologists Gastrointestinal Cancers Symposium (ASCO GI) kicked off the year with lots of new data in the f...
DiCE Supports Act4Biosimilars to Increase Patient Access to Biologic Medicines
On 30 January, the Act4Biosimilars initiative hosted a virtual meeting with key stakeholders from across the healthcare space to discuss the Action...
16 February is World Cholangiocarcinoma Day
DiCE is proud to support GCCA’s international effort to raise much-needed awareness of CCA, devastating cancer that occurs in the bile ducts in o...
Interventions to Reduce Cancer Screening Inequities
A group of patients and patient advocacy organisations published a promising multistep strategy to reduce cancer screening inequalities In Internat...
First Immunotherapy Drug Durvalumab Plus Chemotherapy Approved in Europe for Advanced Biliary Cancer
On 21 December the European Commission (EC) approved the use of durvalumab (Imfinzi ®) plus chemotherapy (gemcitabine plus cisplatin) as the first...
Trastuzumab Deruxtecan Approved as Second-line Treatment in Europe For Patients With HER2-positive Advanced Gastric Cancer
On December 19th the European Commission (EC) approved the use of trastuzumab deruxtecan (Enhertu ®) plus chemotherapy (gemcitabine plus cisplatin...
National Cancer Center Japan Asks for Your Support on a Project to Impact Patient Engagement
Would you like to know how and where patient engagement is happening in R&D? Would you like to see an objective comparison between Europe and J...
COVID-19 impact on healthcare management of people with chronic diseases
The European Patients’ Forum (EPF) conducted a COVID-19 survey between 18 September to 18 October 2020 (the report is available here).&...
Oncology Nurse Practitioner Looking for Help from Those with Higher Cancer Risk
Oncology nurse practitioner, research assistant and Education Working Group co-Chair of the European Oncology Nursing Society (EONS), Celia Díez ...
